Indian drug makers scouting for partners in China: report
Indian pharma firms are seeking partners that can make tangible business contributions, safeguard IP, ensure operational control and manage talent, says a BofA-ML report
Dr Reddy’s, Aurobindo Pharma, Cipla, Sun Pharmaceuticals Industries are looking at China as a big opportunity
Amid stifling competition in its biggest market, the US, Indian drug makers are scouting for partners in China, the world’s second largest drug market. A report by Bank of America Merrill Lynch, released on Monday, estimates more Indian companies will enter the pharma industry in China through joint ventures.
Major pharmaceutical companies in India like Dr Reddy’s Laboratories, Aurobindo Pharma Ltd, Cipla Ltd and Sun Pharmaceuticals Industries Ltd are looking at China as a big opportunity, making the market one of the focus areas for future growth.